Stock HNGZY HANGZHOU TIGERMED CONSULTING CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Hangzhou Tigermed Consulting Co., Ltd OTC Markets

Equities

HNGZY

US41044T1088

Market Closed - OTC Markets
Other stock markets
 11:43:36 2023-12-19 EST 		5-day change 1st Jan Change
4.2 USD -4.55% Intraday chart for Hangzhou Tigermed Consulting Co., Ltd -.--% -.--%
04-25 Hangzhou Tigermed Consulting’s Profit Down 59% in Q1 MT
04-25 Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the First Quarter Ended March 30, 2024 CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Hangzhou Tigermed Consulting’s Profit Down 59% in Q1
MT
Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the First Quarter Ended March 30, 2024
CI
Tigermed Consulting's Profit, Revenue Climb in 2023
MT
Hangzhou Tigermed Consulting Co., Ltd Announces Final Dividend for the Year Ended December 31, 2023, Payable on 31 July 2024
CI
Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
CI
China Healthcare Stocks Rally on Hopes for Government Support
DJ
China stocks steady, helped by biotech rally; Wuxi Apptec drags Hong Kong shares
RE
Hangzhou Tigermed Consulting Plans Up to 1 Billion Yuan Share Repurchase; Shares Jump 4%
MT
Hangzhou Tigermed Consulting Co., Ltd announces an Equity Buyback for CNY 1,000 million worth of its shares.
CI
Hangzhou Tigermed Consulting Co., Ltd announces an Equity Buyback for CNY 1,000 million worth of its shares.
CI
Hangzhou Tigermed Consulting Co., Ltd authorizes a Buyback Plan.
CI
Hangzhou Tigermed Consulting Co., Ltd authorizes a Buyback Plan.
CI
Hangzhou Tigermed Consulting's Profit Up 19% in Q3
MT
Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Tigermed Consulting's Profit Jumps 16.5% in H1
MT
Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Tigermed Officially Opens International Headquarters in Hong Kong
CI
Hangzhou Tigermed Consulting Co., Ltd. Announces Final Profit Distribution Plan Implementation (A Shares) for 2022, Payable on 07 July 2023
CI
Hangzhou Tigermed Consulting Co. Ltd. Proposes Ordinary Final Dividend for the Year Ended December 31, 2022, Payable on 07 July 2023
CI
Hangzhou Tigermed Consulting Co. Ltd. Announces Ordinary Final Dividend for the Year Ended December 31, 2022, Payable on 21 July 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300347 Stock
  4. HNGZY Stock
  5. News Hangzhou Tigermed Consulting Co., Ltd
  6. Highlights